AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30726347 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood collection and accelerometer measurements
Number of subjects: 2796
Study 29544551 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT) - intensive, group, and independent methods
Number of subjects: 720
Study 29544551 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 720
Study 26805535 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated circadian clock group (study group)
Number of subjects: 70
Study 26805535 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine group in simulated circadian clock group
Number of subjects: 70
Study 26805535 — intervention group
Group type: COMPARATOR
Intervention: Propofol group in simulated circadian clock group
Number of subjects: 70
Study 25307535 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved LDL target (< 2.0 mmol/L)
Number of subjects: 448
Study 25307535 — intervention group
Group type: COMPARATOR
Intervention: Statin use
Number of subjects: 448
Study 25307535 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 448
Study 23041150 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragaloside IV (AS-IV)
Number of subjects: 0
Study 20424829 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 14
Study 20424829 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SHAM)
Number of subjects: 14
Study 18022000 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous N-acetylcysteine (NAC) 300 mg along with hydration (500 mL multielectrolyte fluid)
Number of subjects: 112
Study 18022000 — intervention group
Group type: COMPARATOR
Intervention: Hydration (500 mL multielectrolyte fluid) only
Number of subjects: 112
Study 16146256 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mL/kg nebulized L-epinephrine
Number of subjects: 39
Study 16146256 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mL/kg nebulized L-epinephrine
Number of subjects: 39
Study 12163671 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tracer protocol
Number of subjects: 5
Study 12163671 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) tracer protocol
Number of subjects: 5
Study 10485962 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg oral)
Number of subjects: 24
Study 10485962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 10485962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 24
Study 7677832 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck suction stimulation of carotid baroreceptors at 0.1 Hz
Number of subjects: 0
Study 7677832 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck suction stimulation of carotid baroreceptors at 0.2 Hz
Number of subjects: 0
Study 7677832 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting state power spectrum analysis
Number of subjects: 0
Study 2803121 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 4
Study 2803121 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin and Metronidazole
Number of subjects: 4
Study 2803121 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin and Sulbactam
Number of subjects: 4
Study 2803121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 30208393 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in Supported Conversation for Adults with Aphasia
Number of subjects: 80
Study 30208393 — intervention group
Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 80
Study 26672413 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal appliance (NPA)
Number of subjects: 60
Study 26672413 — intervention group
Group type: COMPARATOR
Intervention: Mandibular repositioning splint (MRS)
Number of subjects: 60
Study 26672413 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 60
Study 22410476 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS to left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 16
Study 22410476 — intervention group
Group type: COMPARATOR
Intervention: tDCS to left temporo-parietal cortex (TPC)
Number of subjects: 16
Study 21681507 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 24
Study 21681507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 18356323 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Protein (HP) lunch (25%E protein, 45%E carbohydrate, 30%E fat)
Number of subjects: 0
Study 18356323 — intervention group
Group type: COMPARATOR
Intervention: Appropriate Protein (AP) lunch (10% energy protein, 60%E carbohydrate, 30%E fat)
Number of subjects: 0
Study 18356323 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Protein (HP) lunch
Number of subjects: 0
Study 18356323 — intervention group
Group type: COMPARATOR
Intervention: Appropriate Protein (AP) lunch
Number of subjects: 0
Study 17058887 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular education program (MASA Program) with patient handout and PowerPoint slides, 2-hour teaching program for three times over six months
Number of subjects: 75
Study 17058887 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular education program (MASA Program)
Number of subjects: 75
Study 17058887 — intervention group
Group type: COMPARATOR
Intervention: Control group received a short introduction to peak-flow meter, asthma diary, and emergency instructions
Number of subjects: 75
Study 17058887 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 15002887 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer/fluoride dentifrice
Number of subjects: 60
Study 15002887 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoride dentifrice
Number of subjects: 60
Study 10965648 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention
Number of subjects: 60
Study 10965648 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 60
Study 8632624 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (rtPA)
Number of subjects: 0
Study 8632624 — intervention group
Group type: COMPARATOR
Intervention: Urokinase (UK)
Number of subjects: 0
Study 6703371 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 50
Study 6703371 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 50
Study 6703371 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 50
Study 6703371 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol
Number of subjects: 50
Study 6703371 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (after fentanyl, morphine, or meperidine)
Number of subjects: 50
Study 6703371 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (without narcotics)
Number of subjects: 50
Study 31678952 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-supported prevention programme (10-week duration)
Number of subjects: 60
Study 31678952 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 60
Study 30543702 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit group
Number of subjects: 0
Study 30543702 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuts group
Number of subjects: 0
Study 27124565 — intervention group
Group type: EXPERIMENTAL
Intervention: Family burden assessment using the Infant Toddler Quality of Life Questionnaire (for children <5 years) and the Child Health Questionnaire (for children ≥5 years) at baseline, 3 months, and 12 months post arrest.
Number of subjects: 77
Study 27124565 — intervention group
Group type: EXPERIMENTAL
Intervention: Child functioning assessment using the Vineland Adaptive Behavior Scale II, Pediatric Overall Performance Category, and Pediatric Cerebral Performance Category scales at 3 months post arrest.
Number of subjects: 77
Study 24424141 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ligation and stripping
Number of subjects: 267
Study 24424141 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation
Number of subjects: 267
Study 24424141 — intervention group
Group type: COMPARATOR
Intervention: C2 (simple varicose veins)
Number of subjects: 267
Study 24424141 — intervention group
Group type: COMPARATOR
Intervention: C3-4 (soft tissue complications)
Number of subjects: 267
Study 22711908 — intervention group
Group type: EXPERIMENTAL
Intervention: Class-based delivery strategy
Number of subjects: 5532
Study 22711908 — intervention group
Group type: COMPARATOR
Intervention: Age-based delivery strategy
Number of subjects: 5532
Study 22711908 — intervention group
Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 5532
Study 21045096 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (2 g/d)
Number of subjects: 402
Study 21045096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 402
Study 18062595 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 279
Study 18062595 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 279
Study 15723894 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded exercise therapy
Number of subjects: 49
Study 15723894 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 49
Study 12409185 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT/A (100 mouse units, Dysport)
Number of subjects: 50
Study 12409185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 10210385 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg finasteride daily
Number of subjects: 121
Study 10210385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 10210385 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg finasteride daily in men with prostates larger than 40 cc
Number of subjects: 121
Study 7818120 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms) added to bupivacaine in spinal anesthesia
Number of subjects: 40
Study 7818120 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms) added to bupivacaine in epidural anesthesia
Number of subjects: 40
Study 7818120 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms) added to bupivacaine in both spinal and epidural anesthesia
Number of subjects: 40
Study 7818120 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine alone (without clonidine)
Number of subjects: 40
Study 2103193 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐isosorbide mononitrate (20 mg)
Number of subjects: 15
Study 391626 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% oxymetazoline ophthalmic solution
Number of subjects: 141
Study 391626 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 141
Study 31321763 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 72
Study 31321763 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 72
Study 28973535 — intervention group
Group type: EXPERIMENTAL
Intervention: Movie containing guns
Number of subjects: 104
Study 28973535 — intervention group
Group type: COMPARATOR
Intervention: Movie not containing guns
Number of subjects: 104
Study 26825288 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Birth Attendant (TBA) referral program
Number of subjects: 0
Study 26825288 — intervention group
Group type: COMPARATOR
Intervention: Control group (rural control facilities)
Number of subjects: 0
Study 23307507 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Colonoscopy (SC)
Number of subjects: 13
Study 23307507 — intervention group
Group type: COMPARATOR
Intervention: Colon Capsule Endoscopy (CCE)
Number of subjects: 13
Study 23307507 — intervention group
Group type: COMPARATOR
Intervention: Standard Colonoscopy (SC) and Colon Capsule Endoscopy (CCE)
Number of subjects: 13
Study 21979997 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with meso‐zeaxanthin (10.6 mg), lutein (5.9 mg), and zeaxanthin (1.2 mg)
Number of subjects: 44
Study 21979997 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with meso‐zeaxanthin, lutein, and zeaxanthin
Number of subjects: 44
Study 21979997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 17933885 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational health intervention including consultation and possible referral to specialist treatment.
Number of subjects: 418
Study 17933885 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 418
Study 17933885 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational health intervention (n = 134) with available cost data.
Number of subjects: 418
Study 17933885 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group) with available cost data (n = 138).
Number of subjects: 418
Study 17933885 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational health intervention.
Number of subjects: 418
Study 15647491 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 degrees screen-cursor rotation
Number of subjects: 0
Study 15647491 — intervention group
Group type: COMPARATOR
Intervention: 30 degrees counter-rotation learned 5 min after initial rotation
Number of subjects: 0
Study 15647491 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 degrees counter-rotation learned 24 hr after initial rotation
Number of subjects: 0
Study 15647491 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased initial rotation learning
Number of subjects: 0
Study 12092748 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin alone (20 mg/kg) in Rat Study 1
Number of subjects: 3
Study 12092748 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin with calcium chloride (20 mg/kg) in Rat Study 2
Number of subjects: 3
Study 12092748 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin alone (400 mg) in Study 1 (volunteer study)
Number of subjects: 3
Study 12092748 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin with calcium polycarbophil (400 mg + 1200 mg) in Study 2 (volunteer study)
Number of subjects: 3
Study 10449024 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical Jump (VJ)
Number of subjects: 5
Study 10449024 — intervention group
Group type: EXPERIMENTAL
Intervention: Long Jump (LJ)
Number of subjects: 5
Study 10449024 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclination angle of 75 degrees
Number of subjects: 5
Study 10449024 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclination angle of 65 degrees
Number of subjects: 5
Study 8672319 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.01 EC50)
Number of subjects: 12
Study 8672319 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.06 EC50)
Number of subjects: 12
Study 8672319 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.13 EC50)
Number of subjects: 12
Study 8672319 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.26 EC50)
Number of subjects: 12
Study 8672319 — intervention group
Group type: COMPARATOR
Intervention: Halothane (0 MAC)
Number of subjects: 12
Study 8672319 — intervention group
Group type: COMPARATOR
Intervention: Halothane (0.05 MAC)
Number of subjects: 12
Study 8672319 — intervention group
Group type: COMPARATOR
Intervention: Halothane (0.11 MAC)
Number of subjects: 12
Study 8672319 — intervention group
Group type: COMPARATOR
Intervention: Halothane (0.2 MAC)
Number of subjects: 12
Study 2310357 — intervention group
Group type: EXPERIMENTAL
Intervention: 8,000 ft (2,400 m) hypoxia
Number of subjects: 40
Study 2310357 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 ft (3,000 m) hypoxia
Number of subjects: 40
Study 2310357 — intervention group
Group type: EXPERIMENTAL
Intervention: 15,000 ft (4,500 m) hypoxia
Number of subjects: 40
Study 2310357 — intervention group
Group type: EXPERIMENTAL
Intervention: 12,500 ft (3,800 m) hypoxia
Number of subjects: 40
Study 392699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride supplement in sugar products (10 mg F as NaF per kg of sugar) and NaHCO3 + KH2PO4 mixture in candies (substituting for 2.5% of sugar).
Number of subjects: 84
Study 392699 — intervention group
Group type: COMPARATOR
Intervention: Control group received respective products without additives.
Number of subjects: 84
Study 392699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride supplements in test subjects.
Number of subjects: 84
Study 30244029 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 61
Study 30244029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 27664141 — intervention group
Group type: EXPERIMENTAL
Intervention: Community therapists delivering family therapy as routine standard of care
Number of subjects: 38
Study 25679187 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg as atorvastatin calcium tablets
Number of subjects: 24
Study 25679187 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 24
Study 23944648 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramyocardial injections of 2000 μg plasmid vascular endothelial growth factor 165
Number of subjects: 13
Study 21900702 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel EHR functionality
Number of subjects: 207
Study 21900702 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff physicians
Number of subjects: 207
Study 21900702 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicians graduated more than 10 years ago
Number of subjects: 207
Study 21900702 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher patient volumes
Number of subjects: 207
Study 21900702 — intervention group
Group type: EXPERIMENTAL
Intervention: More documented patient problems
Number of subjects: 207
Study 21900702 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of patient visits
Number of subjects: 207
Study 21900702 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of documented problems
Number of subjects: 207
Study 19250209 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet for 6 months
Number of subjects: 69
Study 18051834 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoprevention
Number of subjects: 0
Study 15473115 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention (scheduled check-up by an occupational therapist using a checklist)
Number of subjects: 216
Study 15473115 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention (user and carer encouraged to initiate contact when necessary)
Number of subjects: 216
Study 15473115 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention
Number of subjects: 216
Study 11157143 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐1Ra 150 mg/day
Number of subjects: 12
Study 11157143 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐1Ra 30 mg/day
Number of subjects: 12
Study 11157143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9593066 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 45
Study 9593066 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 45
Study 7528305 — intervention group
Group type: EXPERIMENTAL
Intervention: temocapril
Number of subjects: 10
Study 7528305 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 3246167 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CRO: Rocephin) 100 mg/kg/day, once daily
Number of subjects: 100
Study 3246167 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin 160 mg/kg/day and chloramphenicol (AMCL) 100 mg/kg/day, every 6 h
Number of subjects: 100
Study 3246167 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CRO)
Number of subjects: 100
Study 3246167 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin and chloramphenicol (AMCL)
Number of subjects: 100
Study 29530747 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen (Ofirmev)
Number of subjects: 72
Study 29530747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 29199345 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing implant template (TDPIT group)
Number of subjects: 30
Study 29199345 — intervention group
Group type: COMPARATOR
Intervention: Conventional implant template (CIT group)
Number of subjects: 30
Study 26259598 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab (CT + B)
Number of subjects: 237
Study 26259598 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (CT) alone
Number of subjects: 237
Study 23971383 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-dihydroergocryptine
Number of subjects: 171
Study 23971383 — intervention group
Group type: COMPARATOR
Intervention: cabergoline
Number of subjects: 171
Study 20373906 — intervention group
Group type: EXPERIMENTAL
Intervention: Prodose Adaptive Aerosol Delivery (AAD) System
Number of subjects: 19
Study 20373906 — intervention group
Group type: EXPERIMENTAL
Intervention: Home delivery of medication
Number of subjects: 19
Study 18230068 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 0.5 microg.kg(‐1)
Number of subjects: 120
Study 18230068 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 1 microg.kg(‐1)
Number of subjects: 120
Study 18230068 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 15 microg.kg(‐1)
Number of subjects: 120
Study 18230068 — intervention group
Group type: COMPARATOR
Intervention: saline 5 ml
Number of subjects: 120
Study 15126521 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 diabetic patients
Number of subjects: 0
Study 15126521 — intervention group
Group type: COMPARATOR
Intervention: Matched nondiabetic controls
Number of subjects: 0
Study 11806474 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1
Number of subjects: 3
Study 11806474 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond NT
Number of subjects: 3
Study 11806474 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental (unfilled NT)
Number of subjects: 3
Study 9483299 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble CPAP
Number of subjects: 10
Study 9483299 — intervention group
Group type: COMPARATOR
Intervention: Ventilator-derived CPAP
Number of subjects: 10